Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia
出版年份 2019 全文链接
标题
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia
作者
关键词
-
出版物
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
Volume -, Issue -, Pages 000486741989343
出版商
SAGE Publications
发表日期
2019-12-12
DOI
10.1177/0004867419893439
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Putative neuroprotective pharmacotherapies to target the staged progression of mental illness
- (2019) Oliver D. Robertson et al. Early Intervention in Psychiatry
- A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
- (2019) Michael Berk et al. BMC Medicine
- Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study
- (2019) Ragy R. Girgis et al. PSYCHIATRY RESEARCH
- An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis
- (2019) N. Çakici et al. PSYCHOLOGICAL MEDICINE
- N -acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials
- (2018) W. Zheng et al. ACTA PSYCHIATRICA SCANDINAVICA
- Oxidative stress predicts cognitive decline with aging in healthy adults: an observational study
- (2018) Ihab Hajjar et al. Journal of Neuroinflammation
- Improvement of cognitive function in schizophrenia with N-acetylcysteine: A theoretical review
- (2018) Caitlin O. B. Yolland et al. NUTRITIONAL NEUROSCIENCE
- Therapeutic effect of adjunctive N -acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial
- (2018) Zahra Sepehrmanesh et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders
- (2018) Alan Breier et al. SCHIZOPHRENIA RESEARCH
- The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study
- (2018) Pernille Kempel Ellegaard et al. JOURNAL OF AFFECTIVE DISORDERS
- The effect of N-acetylcysteine (NAC) on human cognition – A systematic review
- (2017) David R. Skvarc et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
- (2017) Philippe Conus et al. SCHIZOPHRENIA BULLETIN
- Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders
- (2016) K. W. Miskowiak et al. ACTA PSYCHIATRICA SCANDINAVICA
- The neurobiology of MMN and implications for schizophrenia
- (2016) Patricia T. Michie et al. BIOLOGICAL PSYCHOLOGY
- N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
- (2016) Susan L. Rossell et al. BMC Psychiatry
- A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up study
- (2016) R. Daglas et al. EUROPEAN PSYCHIATRY
- N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects
- (2016) Alessandro Minarini et al. Expert Opinion on Drug Metabolism & Toxicology
- The Positive and Negative Syndrome Scale (PANSS): A Three-Factor Model of Psychopathology in Marginally Housed Persons with Substance Dependence and Psychiatric Illness
- (2016) Chantelle J. Giesbrecht et al. PLoS One
- Cognitive effects of adjunctive N-acetyl cysteine in psychosis
- (2016) M. Rapado-Castro et al. PSYCHOLOGICAL MEDICINE
- Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology?
- (2016) P. Steullet et al. SCHIZOPHRENIA RESEARCH
- Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
- (2015) Deepmala et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Towards stage specific treatments: Effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophrenia
- (2015) Marta Rapado-Castro et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Oxidative stress and cognition amongst adults without dementia or stroke: Implications for mechanistic and therapeutic research in psychiatric disorders
- (2015) Dwight F. Newton et al. PSYCHIATRY RESEARCH
- Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries
- (2014) Justin Davis et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Oxidative stress and schizophrenia
- (2014) Francesco E. Emiliani et al. CURRENT OPINION IN PSYCHIATRY
- N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action
- (2014) Olivia Dean et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Special Section on Implications of CATIE: What CATIE Found: Results From the Schizophrenia Trial
- (2014) Marvin S. Swartz et al. PSYCHIATRIC SERVICES
- Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions
- (2014) Petter Andreas Ringen et al. Frontiers in Psychiatry
- N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
- (2013) Mehdi Farokhnia et al. CLINICAL NEUROPHARMACOLOGY
- Executive functioning in schizophrenia: The result of impairments in lower order cognitive skills?
- (2013) Erica Neill et al. SCHIZOPHRENIA RESEARCH
- The promise of N-acetylcysteine in neuropsychiatry
- (2013) Michael Berk et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Mismatch Negativity: Translating the Potential
- (2013) Juanita Todd et al. Frontiers in Psychiatry
- N-acetylcysteine for major depressive episodes in bipolar disorder
- (2011) Pedro V Magalhães et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- The MATRICS Consensus Cognitive Battery (MCCB): Clinical and cognitive correlates
- (2011) Sharon M. August et al. SCHIZOPHRENIA RESEARCH
- P03-101 N-Acetyl-cysteine in augmentation to atypical antipsychotics improves cognitive symptoms in subjects with schizophrenia
- (2010) A.E. Di Rosa et al. EUROPEAN PSYCHIATRY
- Comparative antilipidemic effect of N-acetylcysteine and sesame oil administration in diet-induced hypercholesterolemic mice
- (2010) Laskarina-Maria Korou et al. Lipids in Health and Disease
- N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search